Technology | Blood Testing
Abbott recently announced that its Architect Stat High Sensitivity Troponin-I blood test has received clearance from the U.S. Food and Drug Administration (FDA). As one of the most researched troponin diagnostic tests, doctors in the U.S. can now utilize this proven technology to help detect heart attacks faster and more accurately than contemporary troponin tests.
October 09, 2019
Videos | Heart Valve Technology
Torsten Vahl, M.D., director of experimental and translational research, Structural Heart and Valve Center and at the ...
October 09, 2019
News | Stent Grafts
Medtronic plc announced it has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its Valiant TAAA Stent Graft System for minimally invasive repair of thoracoabdominal aortic aneurysm (TAAA). A TAAA is a complex condition causing a bulging of the aorta, which extends from the chest down into the abdomen.
October 09, 2019Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
News
October 9, 2019 — Medtronic is recalling the 6 French Sherpa NX Active Guide Catheter due to a risk of the outer ...
October 09, 2019
News | ACC
Douglas Drachman, M.D., FACC, has been selected as the next vice chair of the American College of Cardiology’s (ACC) Annual Scientific Session. Drachman will serve as vice chair for ACC.21 and ACC.22 and transition to chair for ACC.23 and ACC.24.
October 08, 2019
News | Stent Grafts
PQ Bypass Inc. announced it has received full approval of its investigational device exemption (IDE) trial of the company’s Torus stent graft. The novel stent graft platform is designed for the treatment of peripheral artery disease (PAD) in the superficial femoral artery (SFA). By acquiring early U.S. Food and Drug Administration (FDA) feedback through the pre-submission process, the TORUS-2 study (The PQ Bypass pivOtal IDE intra-aRterial stent graft study for occlUsive and re-Stenotic fem-pop revascularization) is the company’s second IDE approved in less than two years and is the first pivotal IDE for an SFA stent graft since Viabahn received initial premarket approval (PMA) in 2005.
October 08, 2019Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
American Heart Association President Robert Harrington, M.D., explains the reasons for shorter duration dual-antiplatelet therapy (DAPT) in high-risk bleeding patient
October 08, 2019
Videos | Cardiogenic Shock
William O’Neill, M.D., medical director of the Center for Structural Heart Disease at Henry Ford Hospital, Detroit, explains data on first 250 patients in the National Cardiogenic Shock Initiative Study (NCSI) and new escalation protocols
October 08, 2019
360 Photos | 360 View Photos
Henry Ford Hospital in Detroit gets a lot of referrals for very sick patients seeking a last resort treatment in its ...
October 08, 2019Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
Feature | Sudden Cardiac Arrest
October 7, 2019 — Glynn Crawford was hospitalized at University Hospitals Ahuja Medical Center in late June/early July ...
October 07, 2019
October 7, 2019 – A recent study published in the New England Journal of Medicine supports the use of cardiac magnetic ...
October 07, 2019
Videos | TCT
Chandan Devireddy, M.D., offers insights about what he saw as the top take aways from the 2019 Transcatheter ...
October 04, 2019Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
News | Heart Valve Technology
October 4, 2019 – A new analysis of the PARTNER 3 Trial data found a modest, but significant, improvement in one-year ...
October 04, 2019
News | Heart Failure
October 4, 2019 – Results of a new economic analysis of the COAPT Trial data found that transcatheter mitral valve ...
October 04, 2019
News
October 4, 2019 – RenalGuard Therapy was found to be superior to the POSEIDON method in preventing contrast-induced ...
October 04, 2019© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now